» Articles » PMID: 23609145

Inhibition of the Proton-coupled Folate Transporter (PCFT-SLC46A1) by Bicarbonate and Other Anions

Overview
Journal Mol Pharmacol
Date 2013 Apr 24
PMID 23609145
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

The proton-coupled folate transporter (PCFT) plays a key role in intestinal folate absorption, and loss-of-function mutations in the gene encoding this transporter are the molecular basis for hereditary folate malabsorption. Using a stable transfectant with high expression of PCFT, physiologic levels of bicarbonate produced potent and rapidly reversible inhibition of PCFT-mediated transport at neutral pH. Bisulfite and nitrite also inhibited PCFT function at neutral pH, whereas sulfate, nitrate, and phosphate had no impact at all. At weakly acidic pH (6.5), bisulfite and nitrite exhibited much stronger inhibition of PCFT-mediated transport, whereas sulfate and nitrate remained noninhibitory. Inhibition by bisulfite and nitrite at pH 6.5 was associated with a marked decrease in the influx Vmax and collapse of the transmembrane proton gradient attributed to the diffusion of the protonated forms into these cells. Monocarboxylates such as pyruvate and acetate also collapsed the pH gradient and were also inhibitory, whereas citrate and glycine neither altered the proton gradient nor inhibited PCFT-mediated transport. These observations add another dimension to the unfavorable pH environment for PCFT function in systemic tissues: the presence of high concentrations of bicarbonate.

Citing Articles

Discovery of Tumor-Targeted 6-Methyl Substituted Pemetrexed and Related Antifolates with Selective Loss of RFC Transport.

Kaku K, Ravindra M, Tong N, Choudhary S, Li X, Yu J ACS Med Chem Lett. 2023; 14(12):1682-1691.

PMID: 38116433 PMC: 10726441. DOI: 10.1021/acsmedchemlett.3c00326.


Biology and therapeutic applications of the proton-coupled folate transporter.

Matherly L, Schneider M, Gangjee A, Hou Z Expert Opin Drug Metab Toxicol. 2022; 18(10):695-706.

PMID: 36239195 PMC: 9637735. DOI: 10.1080/17425255.2022.2136071.


The evolving biology of the proton-coupled folate transporter: New insights into regulation, structure, and mechanism.

Hou Z, Gangjee A, Matherly L FASEB J. 2022; 36(2):e22164.

PMID: 35061292 PMC: 8978580. DOI: 10.1096/fj.202101704R.


Folate Transport and One-Carbon Metabolism in Targeted Therapies of Epithelial Ovarian Cancer.

Wallace-Povirk A, Hou Z, Nayeen M, Gangjee A, Matherly L Cancers (Basel). 2022; 14(1).

PMID: 35008360 PMC: 8750473. DOI: 10.3390/cancers14010191.


Therapeutic Targeting of Mitochondrial One-Carbon Metabolism in Cancer.

Dekhne A, Hou Z, Gangjee A, Matherly L Mol Cancer Ther. 2020; 19(11):2245-2255.

PMID: 32879053 PMC: 7921203. DOI: 10.1158/1535-7163.MCT-20-0423.


References
1.
Henderson G, Zevely E . Structural requirements for anion substrates of the methotrexate transport system in L1210 cells. Arch Biochem Biophys. 1983; 221(2):438-46. DOI: 10.1016/0003-9861(83)90162-5. View

2.
Zhao R, Gao F, Wang Y, Diaz G, Gelb B, Goldman I . Impact of the reduced folate carrier on the accumulation of active thiamin metabolites in murine leukemia cells. J Biol Chem. 2000; 276(2):1114-8. DOI: 10.1074/jbc.M007919200. View

3.
Umapathy N, Gnana-Prakasam J, Martin P, Mysona B, Dun Y, Smith S . Cloning and functional characterization of the proton-coupled electrogenic folate transporter and analysis of its expression in retinal cell types. Invest Ophthalmol Vis Sci. 2007; 48(11):5299-305. PMC: 3850295. DOI: 10.1167/iovs.07-0288. View

4.
Vonderschmitt D, Vitols K, Huennekens F, SCRIMGEOUR K . Addition of bisulfite to folate and dihydrofolate. Arch Biochem Biophys. 1967; 122(2):488-93. DOI: 10.1016/0003-9861(67)90223-8. View

5.
Zhao R, Diop-Bove N, Visentin M, Goldman I . Mechanisms of membrane transport of folates into cells and across epithelia. Annu Rev Nutr. 2011; 31:177-201. PMC: 3885234. DOI: 10.1146/annurev-nutr-072610-145133. View